Likewise, the clonogenic assay showed that overexpression of UBE2S significantly decreased the Olaparib sensitivity in ovarian cancer cells, in which the cell growth was obviously enhanced (Fig. 4E and F). Here, UBE2S is linked to ovarian carcinoma.